Tarsus Pharmaceuticals reported total assets of $611.14M and total liabilities of $264.41M for the quarter ended Jun 2026, up 23.5% year over year. This balance sheet covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||||||||
| Current Assets | ||||||||||||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 183.80M | 171.33M | 175.01M | 245.40M | 169.49M | 71.66M | 66.00M | 106.77M | 226.67M | 224.95M | 193.71M | 181.09M | 176.21M | 94.82M | 175.79M | 96.65M | 112.72M | 183.64M | 102.19M | 204.59M | ||||||||
| Short-term InvestmentsInvestments (Current) | 0.48M | 0.29M | 57.08M | 145.37M | 135.22M | 71.45M | 20.21M | 2.50M | 104.82M | 142.49M | 140.74M | 196.56M | 232.13M | 284.50M | 289.11M | 233.63M | 286.54M | 245.09M | ||||||||||
| Cash & Current Investments | 183.80M | 171.81M | 175.30M | 245.40M | 226.57M | 217.03M | 201.22M | 178.23M | 246.88M | 227.44M | 298.52M | 323.58M | 316.95M | 291.38M | 407.92M | 381.14M | 401.84M | 417.27M | 388.73M | 449.69M | ||||||||
| Receivables - NetNet Receivables | 0.02M | 0.02M | 0.02M | 2.50M | 5.36M | 16.62M | 29.89M | 29.53M | 29.16M | 46.76M | 62.43M | 58.33M | 72.62M | 85.06M | 100.34M | 96.03M | ||||||||||||
| Receivables - OtherOther Receivables | 0.14M | -0.05M | 0.31M | 0.60M | 3.39M | 3.58M | -3.17M | 0.25M | 1.01M | 0.08M | 1.48M | 1.31M | 1.15M | 0.15M | 1.73M | 1.91M | 1.72M | 0.34M | 16.86M | 2.28M | ||||||||
| Receivables | -0.05M | 0.32M | 0.62M | 3.41M | 3.58M | -0.67M | 6.37M | 16.70M | 31.36M | 30.84M | 30.30M | 46.91M | 64.15M | 60.24M | 74.34M | 85.39M | 117.21M | 98.31M | ||||||||||
| Raw Materials | 2.53M | 2.53M | ||||||||||||||||||||||||||
| Work In Process | 0.39M | 0.68M | 1.20M | 1.59M | 0.61M | 0.76M | 1.58M | 1.00M | 1.41M | 1.63M | 1.36M | |||||||||||||||||
| Finished Goods | 0.18M | 0.83M | 1.00M | 1.25M | 2.01M | 1.94M | 2.29M | 2.83M | 2.96M | 2.94M | 3.02M | |||||||||||||||||
| Inventory | 0.01M | 3.11M | 4.04M | 2.19M | 2.85M | 2.62M | 2.71M | 3.87M | 3.84M | 4.37M | 4.57M | 4.38M | ||||||||||||||||
| Prepaid Assets | 3.15M | 4.04M | 3.13M | 4.30M | 3.49M | 4.77M | 4.51M | 5.00M | 6.01M | 7.87M | 6.80M | 5.97M | 7.01M | 14.65M | 6.00M | 29.17M | 21.70M | 13.47M | 26.72M | 9.61M | ||||||||
| Current Assets | 187.09M | 175.95M | 178.75M | 250.28M | 234.08M | 225.38M | 208.65M | 183.48M | 259.28M | 256.13M | 340.72M | 362.59M | 357.12M | 356.70M | 480.77M | 474.43M | 501.70M | 522.78M | 537.23M | 561.99M | ||||||||
| Non-Current Assets | ||||||||||||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.52M | 0.76M | 0.92M | 0.96M | 0.95M | 0.96M | 1.19M | 1.54M | 1.61M | 1.47M | 1.34M | 2.24M | 2.39M | 2.31M | 2.79M | 3.18M | 5.75M | 11.66M | 17.67M | 20.49M | ||||||||
| Long-Term Investments | 0.17M | 0.16M | 0.37M | 0.31M | 0.32M | 0.21M | 0.63M | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M | 3.87M | 3.87M | 6.68M | ||||||||||||
| Intangibles | 3.97M | 3.87M | 3.77M | 3.67M | 8.57M | 8.33M | 8.09M | 7.85M | 7.61M | 7.37M | 7.13M | 6.88M | ||||||||||||||||
| Goodwill & Intangibles | 3.97M | 3.87M | 3.77M | 3.67M | 8.57M | 8.33M | 8.09M | 7.85M | 7.61M | 7.37M | 7.13M | 6.88M | ||||||||||||||||
| Other Non-Current Assets | 1.61M | 1.13M | 0.89M | 0.60M | 0.58M | 0.58M | 0.53M | 1.45M | 1.25M | 1.51M | 1.32M | 0.85M | 0.89M | 2.60M | 2.56M | 2.56M | 2.56M | 2.00M | 2.00M | 2.00M | ||||||||
| Non-Current Assets | 3.32M | 2.96M | 2.73M | 2.54M | 2.39M | 2.49M | 2.57M | 5.45M | 9.05M | 9.36M | 8.55M | 14.26M | 19.18M | 20.29M | 19.98M | 20.57M | 32.86M | 39.38M | 43.91M | 49.15M | ||||||||
| Assets | 190.41M | 178.91M | 181.48M | 252.83M | 236.47M | 227.86M | 211.21M | 188.93M | 268.33M | 265.49M | 349.28M | 376.84M | 376.30M | 376.99M | 500.75M | 494.99M | 534.56M | 562.16M | 581.13M | 611.14M | ||||||||
| Liabilities | ||||||||||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||||||||||
| Accounts Payables | 0.40M | 9.42M | 16.39M | 24.13M | 40.14M | |||||||||||||||||||||||
| Payables | 0.40M | 9.42M | 16.39M | 24.13M | 40.14M | |||||||||||||||||||||||
| Accumulated Expenses | 8.12M | 8.68M | 10.80M | 8.94M | 10.18M | 9.91M | 9.05M | 9.46M | 15.35M | 23.69M | 36.57M | 43.53M | 54.54M | 55.37M | 76.38M | 78.64M | 103.50M | 101.53M | 110.85M | 123.72M | ||||||||
| Other Accumulated Expenses | ||||||||||||||||||||||||||||
| Total Current Liabilities | 10.37M | 11.48M | 12.61M | 11.72M | 14.27M | 15.43M | 13.26M | 14.77M | 23.25M | 36.94M | 42.53M | 51.57M | 65.87M | 80.61M | 86.31M | 90.25M | 117.05M | 135.69M | 143.51M | 175.75M | ||||||||
| Non-Current Liabilities | ||||||||||||||||||||||||||||
| Non-Current Debt | 19.18M | 19.26M | 19.36M | 19.43M | 24.52M | 24.61M | 29.71M | 29.82M | 29.93M | 71.58M | 71.71M | 71.84M | 71.98M | 72.13M | 72.28M | 72.44M | 72.60M | 72.76M | ||||||||||
| Preferred Stock Liabilities | ||||||||||||||||||||||||||||
| Other Non-Current Liabilities | 0.91M | 0.70M | 0.50M | 0.34M | 0.21M | 0.10M | 0.04M | 1.83M | 1.71M | 1.75M | 1.61M | 1.45M | 1.24M | 10.15M | 10.60M | 16.08M | 15.89M | |||||||||||
| Total Non-Current Liabilities | 10.37M | 11.48M | 31.79M | 30.98M | 33.63M | 34.86M | 37.77M | 39.37M | 52.96M | 66.75M | 72.46M | 123.15M | 137.58M | 152.46M | 189.33M | 208.13M | 216.10M | 248.51M | ||||||||||
| Total Liabilities | 11.27M | 12.18M | 32.29M | 31.32M | 33.84M | 34.96M | 37.81M | 41.20M | 54.67M | 68.50M | 74.07M | 124.60M | 138.82M | 152.46M | 158.29M | 162.38M | 199.48M | 218.73M | 232.18M | 264.41M | ||||||||
| Shareholder's Equity | ||||||||||||||||||||||||||||
| Total Debt | 19.18M | 19.26M | 19.36M | 19.43M | 24.52M | 24.61M | 29.71M | 29.82M | 29.93M | 71.58M | 71.71M | 71.84M | 71.98M | 72.13M | 72.28M | 72.44M | 72.60M | 72.76M | ||||||||||
| Common Equity | 179.14M | 166.73M | 149.20M | 221.50M | 202.63M | 192.90M | 173.40M | 147.73M | 213.66M | 196.99M | 275.21M | 252.25M | 237.48M | 224.53M | 342.46M | 332.61M | 335.08M | 343.43M | 348.95M | 346.73M | ||||||||
| Liabilities and Shareholders Equity | 190.41M | 178.91M | 181.48M | 252.83M | 236.47M | 227.86M | 211.21M | 188.93M | 268.33M | 265.49M | 349.28M | 376.84M | 376.30M | 376.99M | 500.75M | 494.99M | 534.56M | 562.16M | 581.13M | 611.14M | ||||||||
| Retained Earnings | 210.96M | 213.40M | 216.10M | 294.15M | 297.80M | 301.73M | 305.65M | 311.35M | 416.42M | 441.64M | 555.65M | 566.09M | 574.23M | 584.56M | 727.70M | 738.24M | 753.04M | 769.67M | 782.84M | 799.43M | ||||||||
| Treasury Shares |